Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)
Saved in:
| Main Authors: | Francesco Angelucci, Zuzana Nedelska, Blanka Napravnikova Manová, Alžbeta Katonová, Vanesa Jurášová, Daniela Svetlikova, Martin Vyhnálek, Jakub Hort |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.4c10959 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinctive autophagy/mitophagy biomarker profiles in frontotemporal lobar degeneration and Alzheimer’s disease
by: Kateřina Veverová, et al.
Published: (2025-02-01) -
Lewy-MSA hybrid fold drives distinct neuronal α-synuclein pathology
by: Masahiro Enomoto, et al.
Published: (2025-06-01) -
Polymorphisms in the <i>SNCA</i> gene and the risk of synucleopathy
by: Natalia Yu. Abramycheva, et al.
Published: (2025-04-01) -
Dementia With Lewy Bodies (Dlb) Diagnosis Rates vs. National Benchmarks: A Completed Audit Cycle in Manchester Memory Services
by: Ahmed Ghaly, et al.
Published: (2025-06-01) -
Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD
by: Maria Camila Gonzalez, et al.
Published: (2025-05-01)